Drug intelligence / Profile preview

MYCB1-BDO

Development stage: Unknown
Lead developer: MYCB1
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral, Sublingual

Overview

MYCB1-BDO is a full-spectrum medical cannabis oil extract developed and manufactured by MYCB1. It is derived from the standardized Bediol® cannabis cultivar (specifically the 'Elida' strain) sourced from Bedrocan. The formulation, such as MYCB1-BDO 25:30, contains a balanced ratio of tetrahydrocannabinol (THC) and cannabidiol (CBD), typically formulated as an oily cannabis resin solution (Ölige Cannabisharzöl-Lösung) for oral or sublingual administration. It is prescribed in Germany and other European markets for the management of conditions such as chronic pain, spasticity associated with multiple sclerosis, and palliative care.

Brand names: MYCB1-BDOMYCB-1-BDOMYCB 1-BDOMYCB1-BDO 25:30
Other names: Bediol extractBediol oilÖlige Cannabisharzöl-Lösung MYCB1-BDO 25:30

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on MYCB1-BDO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYCB1-BDO.

Explore the full profile